HA

Harsh Ashit Mehta

Active Director Director DIN 02673339
DIN 02673339 First appointment Nov 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 2 historical roles
Total affiliations 7 Since Nov 2010
Shareholding value •••• Premium profile

About Harsh Ashit Mehta

Data last updated:

Harsh Ashit Mehta is a Director at Bo-Chem Private Limited (since 2010), Director at Sunrise Auxichem Private Limited (since 2017) and Director at Oncure Drugs Private Limited (since 2020), and holds 2 more current directorships. The companies operate in Pharma, Chemicals and Materials and Equipment & Machinery. The 3 current companies with reported revenue have a combined latest revenue of ₹12.39 Cr; the largest is Bo-Chem Private Limited at ₹7.82 Cr (FY 2024). Earlier, Harsh Ashit Mehta was a Director at Mazda Healthclub Equipments Private Limited (2019–2021) and Director at Vks Healthclub Equipments Private Limited (2019–2021).

DIN 02673339
Primary Designation Director
Industry Pharma
First Appointment 27 Nov 2010
Oldest Company Age 46 yrs
Largest company Bo-Chem Private Limited · ₹7.82 Cr (FY 2024)
Combined revenue ₹12.39 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bo-Chem Private Limited U24100MH1980PTC022617
Director27 Nov 20101980₹7.82 Cr (FY 2024)Active
Sunrise Auxichem Private Limited U24200MH2007PTC174993
Director24 Jul 20172007₹4.51 Cr (FY 2025)Active
Oncure Drugs Private Limited U24290MH2020PTC350724
Director25 Nov 20202020₹6.4 Lakh (FY 2024)Active
Designated Partner20 Apr 20212021Active
Designated Partner15 Apr 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Jun 20192002₹4.7 Lakh (FY 2020)Converted To Llp
Director24 Jun 20192002₹2.2 Lakh (FY 2020)Converted To Llp

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Harsh Ashit Mehta

Directorship timeline

Open interactive timeline →
Mazda Healthclub Equipments Llp
Vks Healthclub Equipments Llp
Bo-Chem Private Limited
Sunrise Auxichem Private Limited
Premium access

Shareholding and investment profile for Harsh Ashit Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harsh Ashit Mehta

Harsh Ashit Mehta currently holds 5 directorships: Bo-Chem Private Limited (Director, since 27 Nov 2010, revenue ₹7.82 Cr (FY 2024)); Sunrise Auxichem Private Limited (Director, since 24 Jul 2017, revenue ₹4.51 Cr (FY 2025)); Oncure Drugs Private Limited (Director, since 25 Nov 2020, revenue ₹6.4 Lakh (FY 2024)); Mazda Healthclub Equipments Llp (Designated Partner, since 20 Apr 2021); Vks Healthclub Equipments Llp (Designated Partner, since 15 Apr 2021).

Harsh Ashit Mehta was first appointed on 27 Nov 2010 as Director at Bo-Chem Private Limited. The most recent appointment on record is 20 Apr 2021 at Mazda Healthclub Equipments Llp.

The 3 current companies of Harsh Ashit Mehta that report revenue have a combined latest revenue of ₹12.39 Cr: Bo-Chem Private Limited ₹7.82 Cr (FY 2024); Sunrise Auxichem Private Limited ₹4.51 Cr (FY 2025); Oncure Drugs Private Limited ₹6.4 Lakh (FY 2024).

Harsh Ashit Mehta held 2 earlier board appointments: Mazda Healthclub Equipments Private Limited (Director, 24 Jun 2019 to 19 Apr 2021); Vks Healthclub Equipments Private Limited (Director, 24 Jun 2019 to 14 Apr 2021).

The current boards of Harsh Ashit Mehta's companies include Ashit Sumanlal Mehta (Bo-Chem Private Limited), Mangesh Shridhar Revdekar (Bo-Chem Private Limited), Bhargavi Ashit Mehta (Sunrise Auxichem Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available